As the U.S. stock market continues to rally following President Trump's return to office, investors are closely watching the impact of new policies on various sectors. In this context, penny ...

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50 ...

James analyst Gary Nachman maintained an Outperform rating on AbbVie stock (NYSE:ABBV) with a $218.00 price target. The ...

The Stargate Project, a $500B initiative focused on artificial intelligence, lifted AI-driven biotech stocks this week while boosting an unlikely winner, Metagenomi (NASDAQ:MGX), which benefitted from ...

Abcellera, and Valence Discovery. There's not much information yet about Isomorphic Labs' strategy, other than a general statement that the company will build "a computational platform to ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

1 Day ABCL -1.14% DJIA -0.32% S&P Mid Cap 400 -0.08% Health Care/Life Sciences -0.52% ...

Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...

NeuroPace Expects FY25 Revenue Of $92M – $96M (Est $91.239M), Gross Margin Of 73% – 75% Littelfuse Expects Q1 FY25 Net Sales Of $520M - $550M (Est $540.992M), Adjusted EPS Of $1.70 - $1.90 ...

AbCellera Vancouver, Canada 2012 Public co. AbSci Washington, US 2011 Public co. Antiverse Cardiff, Wales 2017 $2.1M BigHat Biosciences California,US 2019 $99.3M ImmunitoAI Bangalore, India 2020 ...

After hours: 7:57:35 p.m. EST ...